davita glp-1 Diabetes patients now have access to first generic medication: ‘More accessible and affordable’ DaVita Newsroom

The clinic focuses on safe, long-term solutions rather than quick fixes, on long-term skin health rather than short-term cosmetic results

For example, our plastic surgeon in San Antonio, TX, often performs a QuickLift and liposuction in the same procedure

Everything from consultations to prescriptions and follow-ups is managed through the PlushCare app

If you see these patterns in any GLP-1 telehealth platform's marketing, they are the exact claims FDA has called misleading: Calling compounded semaglutide or tirzepatide a "generic" version of Ozempic or Wegovy - compounded drugs are not FDA-approved generics Implying FDA approved or reviewed the compounded product for safety, effectiveness, or quality - the FDA hasn't Claiming the pharmacy is "FDA-approved" or "FDA-licensed" - FDA registers facilities but does not "approve" or "license" compounding pharmacies in the way that phrase implies Branding compounded medication with the telehealth company's name in a way that suggests the telehealth company is the compounder - they're not Any messaging that implies the compounded product is "clinically proven" to perform the same as the FDA-approved branded drug This article avoids all of those patterns